| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.073 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |